Fdanews.com just published an article on the possibility of FDA and other global regulatory bodies forming a coalition called the International Coalition of Medical Regulatory Authorities (ICMRA). The goal of the ICMRA is not to develop identical standards, but to provide the world with “high-level, strategic advocacy” on quality. This idea comes from FDA, EMA, and Health Canada sharing data on quality inspections of industry facilities. ICMRA has been an idea for years, but there are still some major issues to overcome before they start the coalition. To read the full article click here.
Obstacles Facing Biosimilars
Still in its infancy in the U.S., the industry faces some growing pains.
Life Science Accelerated
Our experts are dedicated to expediting life science product development regulatory pathways.